Friday, November 13, 2015
As part of good clinical practice (GCP), life sciences teams must develop trial master files (TMFs) and maintain the documents well after the product launch window. Historically, such files were comprised largely of paper-based documents. According to a new study by Cutting Edge Information, however, surveyed global teams report that each of their current TMFs is 54% electronic-based. And that portion is expected to increase to 88% by 2020.